The FDA has approved a first-of-its-kind wearable electrical device — Optune Pax (Novocure) — for patients with locally ...

First approved therapy for locally advanced disease in almost three decades ...

The Swiss biopharmaceutical company’s shares surged in after-hours trading after it said the FDA approved its Optune Pax ...

Even before a tumor in the pancreas becomes discernible, an activated cancer gene actively remodels its future environment ...

Your pancreas has important jobs to do. A large gland behind the lower part of the stomach, it produces hormones that ...

A spokesperson for the charity said as symptoms can be vague, pancreatic cancer is difficult to diagnose at an early stage.

Pancreatic cancer is one of the most lethal forms of cancer, and it’s crucial to understand why. Learn about the challenges in diagnosing and treating this aggressive disease, and why early detection ...

Learn how everyday habits like smoking, poor diet, obesity and alcohol raise pancreatic cancer risk, plus smart lifestyle ...

In a lab-grown cell study focused on potential new treatment targets for halting the spread of most pancreatic cancers, Johns ...

The biochemist’s company, Vega Oncotargets, has toned down its message after the false expectations generated by the ...

A first-of-its-kind device for pancreatic cancer treatment has been approved by the U.S. Food and Drug Administration.

The FDA has approved a new tumor treating fields (TTF) therapy, Optune Pax, for the treatment of adult patients with locally ...